2018 American Transplant Congress
Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for the Treatment of Medically Refractory Hepatic Encephalopathy (HE) in Patients with ESLD and Significant Portal-Venous Shunting
Liver and Pancreas Transplantation, Dumont-UCLA Liver Transplant Center, Los Angeles, CA.
Background: Patients with medical refractory HE represent a challenging group of patients. Plagued by repeated hospitalizations, long lengths of stay (LOS) and high healthcare costs,…2018 American Transplant Congress
The Combination of pAMR and Circulating Donor-Specific Antibodies is Even More Associated with Cardiac Allograft Vasculopathy after Heart Transplant
Cedars Sinai Medical Center, Los Angeles.
Purpose: Several reports have correlated the development of donor-specific antibody (DSA) to the development of cardiac allograft vasculopathy (CAV) after heart transplantation (HTx). Interestingly, patients…2017 American Transplant Congress
Angioplasty versus Stent in the Treatment of Transplant Renal Artery Stenosis.
Objective: To compare restenosis rates and treatment efficacy between percutaneous transluminal angioplasty and stent placement in the treatment of transplant renal artery stenosis.Methods: We conducted…2017 American Transplant Congress
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.
Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…2016 American Transplant Congress
Predicting Obstructive Coronary Artery Disease in Asymptomatic Patients Undergoing Renal Transplantation Using a Simple Risk Score.
Imperial College Kidney and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
PurposeCoronary angiography in asymptomatic patients with End Stage Renal Disease (ESRD) shows significant Coronary Artery Disease (CAD) (stenosis >50%) in 37-53% of patients. We have…2016 American Transplant Congress
Common Iliac Artery Stenosis: An Often Overlooked Cause of Graft Dysfunction.
Nephrology, University of Alberta, Edmonton, AB, Canada.
Transplant renal artery stenosis (TRAS) has been an increasingly recognized complication post kidney transplantation, and a potentially reversible cause for hypertension and allograft dysfunction. This…2016 American Transplant Congress
Planning Genitourinary Vascularized Composite Allotransplantation: A Pre-Operative Imaging Protocol.
Massachusetts General Hospital, Boston, MA.
Study purpose: To define the ideal pre-operative imaging protocol necessary for proper planning of a genitourinary vascularised composite allotransplantation (GUVCA) procedure.Methods: The multidisciplinary GUVCA team…2016 American Transplant Congress
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.
Background: The renal allograft function and blood pressure (BP) control after renal artery angioplasty±stenting for transplant renal artery stenosis (TRAS) is unclear. We aim to…2015 American Transplant Congress
Clinical and Radiological Predictors of Transplant Renal Artery Stenosis (TRAS)
Elevated peak systolic velocity (PSV) on Doppler ultrasound at the transplant renal artery (TRA) does not always correlate with true transplant renal artery stenosis (TRAS)…2015 American Transplant Congress
Negative Exercise Myocardial Perfusion Scintigraphy Discards Silent Coronary Artery Disease in High Cardiovascular Risk Patients Awaiting for Kidney Transplantation
Study Purpose:Screening for silent coronary artery disease (SCAD) in patients awaiting kidney transplantation is still controversial. Indeed, guidelines of some scientific societies show important discrepancies.…
American Transplant Congress abstracts